Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer

NCT00846612 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Doxil
DRUG: Bevacizumab (Avastin)

Sponsor

NYU Langone Health

Collaborators

[object Object]
[object Object]